Literature DB >> 2373598

Subglottic hemangiomas in infants: treatment with intralesional corticosteroid injection and intubation.

J Meeuwis1, C E Bos, L J Hoeve, E van der Voort.   

Abstract

Six children with a subglottic hemangioma were treated in the Sophia Children's Hospital in the period 1982-1987 by means of intralesional corticosteroid injection, followed by intubation. After treatment all children were symptomfree. In 3 patients this result was attained after 1 injection, in 2 after 3 injections. One patient needed 5 injections. The average duration of intubation was 19 days (7-36). Three months (1/2-7 1/2) after the onset of therapy all patients were free of symptoms. No serious complications were observed. No patient needed a tracheotomy. The average follow-up period was 3.3 years (1 1/2-5 1/2). The authors feel that not only the effect of intralesional corticosteroids, but also local gentle pressure by the tube is of therapeutic importance. The above-mentioned treatment of subglottic hemangioma in children is now the treatment of choice in our clinic.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2373598     DOI: 10.1016/0165-5876(90)90220-l

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  3 in total

1.  Obstructive lesions of the pediatric subglottis.

Authors:  Jonathan B Ida; J Lindhe Guarisco; Kimsey H Rodriguez; Ronald G Amedee
Journal:  Ochsner J       Date:  2008

Review 2.  Upper Airway Obstruction in Children.

Authors:  Anirban Mandal; Sushil K Kabra; Rakesh Lodha
Journal:  Indian J Pediatr       Date:  2015-06-25       Impact factor: 5.319

3.  The Safety of Intralesional Steroid Injections in Young Children and Their Effectiveness in Anastomotic Esophageal Strictures-A Meta-Analysis and Systematic Review.

Authors:  Annefleur R L van Hal; Rebecca Pulvirenti; Floris P J den Hartog; John Vlot
Journal:  Front Pediatr       Date:  2022-01-28       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.